Predictors and Outcomes of Secondary Prevention Medication in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.

ABSTRACT:

Background

Evidence on factors associated with guideline-directed secondary prevention medication (GDPM) after percutaneous coronary intervention (PCI) and its effect on the prognosis of patients with coronary artery disease (CAD) is lacking in China.

Aims

To ascertain predictors of GDPM in real-world clinical practice and to assess the effect of GDPM on clinical outcomes.

Design

A retrospective cohort study.

Methods

Consecutive patients admitted to Fuwai Hospital between January 2013 and December 2013 were recruited. GDPM comprised aspirin, clopidogrel, statins, β-blockers, and angiotensin-converting enzyme inhibitors/angiotensin Ⅱ receptor blockers. The primary outcome was five-year major adverse cardiovascular event (MACE) (cardiac death, myocardial infarcti

SUBMITTER: Li T 

PROVIDER: S-EPMC8719473 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature